Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate ...Middle East

PR Newswire - News
Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate
LOS ANGELES, July 12, 2022 /PRNewswire/ -- Turn Therapeutics, a biotechnology company developing innovative products for infectious disease, advanced wound care, and dermatology, today announced positive in-vivo data for its therapeutic candidate (GX-03) as a non-invasive treatment for...

Hence then, the article about turn therapeutics announces positive in vivo data for non melanoma skin cancer candidate was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate )

Apple Storegoogle play

Last updated :

Also on site :